Írország - angol - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - calcium acetate - tablet - 500 milligram(s) - calcium; calcium acetate anhydrous

Málta - angol - Medicines Authority

sanofi malta limited - calcium polystyrene sulfonate - powder for oral suspension - calcium polystyrene sulfonate 99.934 % (w/w) - mineral supplements

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium chloride dihydrate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - parental administration of calcium is indicated in the treatment of hypocalcaemia where rapid increase in plasma calcium is required, such as in hypocalcaemic tetany and tetany due to parathyroid deficiency. intravenous calcium is also indicated to antagonise the cardiotoxicity of hyperkalaemia.

Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

approved prescription services ltd - ergocalciferol; calcium lactate; calcium phosphate - oral tablet - 10microgram ; 300mg ; 150mg

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium gluconate monohydrate, quantity: 95.3 mg/ml - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - calcium gluconate monohydrate, quantity: 931 mg - injection, solution - excipient ingredients: calcium saccharate; water for injections - calcium gluconate is a calcium salt used primarily for the prevention and treatment of calcium deficiency. parenteral administation of calcium gluconate is needed in acute hypocalcaemia and hypocalcsemic tetany. it can be given intravenously in the treatment of severe hyper-kalaemia and in overdosage of magnesium sulphate, as calcium is the antagonist of magnesium toxicity. iv injections have been used in the treatment of acute renal biliary and intestinal colic. calcium has been used as an inotrope in cardiac resuscitation. they may also be used for the prevention of hypocalcaemia in exchange transfusions, and in long term electrolyte replacement therapy.

Ciprus - görög - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

fresenius medical care deutschland gmbh (0000001970) else-kroner-str. 1, bad homburg v.d.h., 61352 - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride; sodium (s)-lactate solution; glucose monohydrate - solution for peritoneal dialysis - calcium chloride dihydrate (0010035048) 0,2573g; magnesium chloride hexahydrate (0007791186) 0,1017g; sodium chloride (0007647145) 5,64g; sodium (s)-lactate solution (8000002516) 3,925g base; glucose monohydrate (0005996101) 15g base - hypertonic solutions

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - calcium chloride dihydrate 100 mg/ml; calcium chloride dihydrate 100 mg/ml - solution for injection - 1000 mg/10ml - active: calcium chloride dihydrate 100 mg/ml calcium chloride dihydrate 100 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - parenteral administration of calcium is indicated in the treatment of hypocalcaemia where a rapid increase in plasma calcium is required, such as in hypocalcaemic tetany and tetany due to parathyroid deficiency.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.